Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Tuesday, November 10, 2009, 6:53AM ET - U.S. Markets open in 2 hours and 37 minutes. Dow Up 2.03% Nasdaq  0.00%
Orexigen Therapeutics, Inc. (OREX)On Nov 9: 7.12   0.00 (0.00%)  
MORE ON OREX
Quotes
Charts
News & Info
HereHeadlines
Company
Analyst Coverage
Ownership
Financials

HeadlinesGet Headlines for:
Change Display [ hide $$  edit ]
Thu, Nov 5, 2009
OREXIGEN THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report
EDGAR Online (Thu, Nov 5)
Orexigen 3rd-quarter loss narrows on lower costs
AP (Thu, Nov 5)
New Star Analyst Rankings for Orexigen Therapeutics, Inc.
StarMine (Thu, Nov 5)
Wed, Nov 4, 2009
Orexigen Therapeutics, Inc. Earnings Call scheduled for 5:00 pm ET today
CCBN (Wed, Nov 4)
OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or
EDGAR Online (Wed, Nov 4)
Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results
PR Newswire (Wed, Nov 4)
Vivus shares dive following 3rd-quarter report
AP (Wed, Nov 4)
Q3 2009 OREXIGEN THERAPEUTICS INC Earnings Release - After Market Close
CCBN (Wed, Nov 4)
Tue, Nov 3, 2009
[video] Stocks Under $10: 2 Beaten Down Buys
at TheStreet.com (Tue, Nov 3)
Mon, Nov 2, 2009
Amylin signs weight-loss drug deal with Takeda
AP (Mon, Nov 2)
Don't Expect Amylin to Eat the Obesity Market's Lunch
at Seeking Alpha (Mon, Nov 2)
Amylin Strikes First on Obesity
Zacks.com (Mon, Nov 2)
Fri, Oct 30, 2009
Friday At The Fat Fight
at CNBC (Fri, Oct 30)
Thu, Oct 29, 2009
Orexigen(R) Therapeutics Schedules November 4, 2009 Webcast Discussion of Financial Results for the Third Quarter Ended September 30, 2009
PR Newswire (Thu, Oct 29)
Wed, Oct 28, 2009
Vivus, Analyst in Obesity Drug Side-Effect Spat
at TheStreet.com (Wed, Oct 28)
Tue, Oct 27, 2009
Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society
PR Newswire (Tue, Oct 27)
Arena: 2nd weight loss trial shows cardiac benefit
at Reuters (Tue, Oct 27)
Mon, Oct 26, 2009
Phase III Trial Expenses For Diabetes Treatments Now Forcing Acquisitions Of Small Cap Biotech Firms: FDA Has "Raised The Bar" For Approval Due To Recent Cardiovascular Issues
Wall Street Transcript (Mon, Oct 26)
Sector Snap: Obesity drug makers gain ground
AP (Mon, Oct 26)
Vivus' Mr. Wilson Goes To Washington
at CNBC (Mon, Oct 26)
Older Headlines - Download Recent Headlines
View headlines from:
Add OREX News to My Yahoo!:
Add to My Yahoo! View RSS Feed

Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
Get Headlines for Another Symbol: Symbol Lookup
Stocks In PlayStory Stocks
Full Coverage